Precision BioSciences, Inc. (DTIL)
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific type of immune cell is genetically engineered to recognize and kill cancer cells; PBCAR0191, which is in Phase 1/2a clinical trial in adult patients with R/R NHL or R/R B-cell precursor acute lymphoblastic leukemia, or B-ALL; PBCAR19B, an anti-CD19 CAR T candidate built on the stealth cell platform utilizing a single-step gene edit to minimize the risk of chromosome abnormalities; and PBCAR269A, an investigational allogeneic CAR T immunotherapy targeting BCMA for the treatment of R/R multiple myeloma. The company has development and commercial license agreement with Les Laboratoires Servier to develop allogeneic chimeric antigen receptor T cell therapies for antigen targets, hematological cancer targets beyond CD19, and solid tumor targets; Tiziana Life Sciences to evaluate foralumab, a fully human anti-CD3 monoclonal antibody as a lymphodepleting agent for the potential treatment of cancers; and iECURE, Inc. to develop ARCUS-based gene editing therapies. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.
$69.66M
Mr. Michael Amoroso
194.00
Durham, NC
Mar 28, 2019
37.04
$0.26
3.75
4.37
23.83%
19.36%
4.20
0.13
0.95
0.84
4.37
10.23%
42.46%
Similar stocks (16)
Revolution Medicines, Inc.
RVMD
Cytokinetics, Incorporated
CYTK
Dyne Therapeutics, Inc.
DYN
Day One Biopharmaceuticals, Inc.
DAWN
Stoke Therapeutics, Inc.
STOK
Pliant Therapeutics, Inc.
PLRX
Terns Pharmaceuticals, Inc.
TERN
Alector, Inc.
ALEC
Inozyme Pharma, Inc.
INZY
Black Diamond Therapeutics, Inc.
BDTX
HOOKIPA Pharma Inc.
HOOK
Acumen Pharmaceuticals, Inc.
ABOS
X4 Pharmaceuticals, Inc.
XFOR
Eledon Pharmaceuticals, Inc.
ELDN
Passage Bio, Inc.
PASG
Galera Therapeutics, Inc.
GRTX
ETF Exposure (10)
iShares Micro-Cap ETF
IWC
0.01648%
Vanguard Strategic Small-Cap Equity Fund Investor Shares
VSTCX
0.01%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (16)
Revolution Medicines, Inc.
RVMD
Cytokinetics, Incorporated
CYTK
Dyne Therapeutics, Inc.
DYN
Day One Biopharmaceuticals, Inc.
DAWN
Stoke Therapeutics, Inc.
STOK
Pliant Therapeutics, Inc.
PLRX
Terns Pharmaceuticals, Inc.
TERN
Alector, Inc.
ALEC
Inozyme Pharma, Inc.
INZY
Black Diamond Therapeutics, Inc.
BDTX
HOOKIPA Pharma Inc.
HOOK
Acumen Pharmaceuticals, Inc.
ABOS
X4 Pharmaceuticals, Inc.
XFOR
Eledon Pharmaceuticals, Inc.
ELDN
Passage Bio, Inc.
PASG
Galera Therapeutics, Inc.
GRTX
ETF Exposure (10)
iShares Micro-Cap ETF
IWC
0.01648%
Vanguard Strategic Small-Cap Equity Fund Investor Shares
VSTCX
0.01%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%